{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:08:45Z","timestamp":1790172525174,"version":"4.1.0"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T00:00:00Z","timestamp":1217376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Pharma Physio"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p><jats:list list-type=\"explicit-label\"><jats:list-item><jats:p>Antinociception versus serum morphine concentration relationships were defined in male and female Sprague\u2010Dawley rats administered single intravenous (i.v.) bolus doses of morphine, using the hot plate (2.1\u201314\u00a0mg\/kg) and tail flick tests (1\u20138\u00a0mg\/kg).<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Serum concentrations of morphine and morphine\u20103\u2010glucuronide (M3G), its major metabolite in the rat, were assayed using high\u2010performance liquid chromatography (HPLC) with electrochemical detection.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Significantly higher (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.05) values of peak antinociception (approximately 1.7\u2010fold), as well as the extent and duration of antinociception (approximately fourfold), were observed in male compared with female rats administered 10\u00a0mg\/kg morphine in the hot plate test. Although there were no significant sex\u2010related differences in the area under the serum morphine concentration versus time curve (AUC) at this dose, systemic exposure to M3G (M3G AUC) was significantly higher (approximately twofold;<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.05) in female than male rats.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>In contrast with most previous studies investigating sex differences in morphine antinociception in rats, the antinociceptive effects of single i.v. doses of morphine (1\u20138\u00a0mg\/kg) in the tail flick test did not differ significantly between male and female rats.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Morphine ED<jats:sub>50<\/jats:sub>and EC<jats:sub>50<\/jats:sub>values (95% confidence intervals) for antinociception in the hot plate test were significantly lower (<jats:italic>P\u00a0&lt;<\/jats:italic>\u00a00.05) in male rats (ED<jats:sub>50<\/jats:sub>8.4\u00a0mg\/kg (7.6\u20139.2); EC<jats:sub>50<\/jats:sub>1.8\u00a0nmol\/L (1.5\u20132.1)) compared with female rats (ED<jats:sub>50<\/jats:sub>10.6\u00a0mg\/kg (9.1\u201312.0); EC<jats:sub>50<\/jats:sub>3.7\u00a0nmol\/L (3.4\u20134.1)). However, in the tail flick test, there was no significant difference between male and female rats in ED<jats:sub>50<\/jats:sub>(1.8 (0.4\u20133.3) and 1.4\u00a0mg\/kg (0.4\u20132.5), respectively) or EC<jats:sub>50<\/jats:sub>(0.5 (0.3\u20130.6) and 0.4\u00a0nmol\/L (0.2\u20130.5), respectively) values.<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Supraspinal attenuation of morphine antinociception by M3G may account for these differences.<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p>","DOI":"10.1111\/j.1440-1681.2008.05019.x","type":"journal-article","created":{"date-parts":[[2008,7,30]],"date-time":"2008-07-30T13:17:06Z","timestamp":1217423826000},"page":"20-28","source":"Crossref","is-referenced-by-count":33,"title":["ANTINOCICEPTION VERSUS SERUM CONCENTRATION RELATIONSHIPS FOLLOWING ACUTE ADMINISTRATION OF INTRAVENOUS MORPHINE IN MALE AND FEMALE SPRAGUE\u2010DAWLEY RATS: DIFFERENCES BETWEEN THE TAIL FLICK AND HOT PLATE NOCICEPTIVE TESTS"],"prefix":"10.1111","volume":"36","author":[{"given":"Samantha M","family":"South","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree T","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(89)90197-4"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(89)90363-8"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0031-9384(93)90042-E"},{"key":"e_1_2_6_5_2","first-page":"767","article-title":"Gender\u2010related differences in the antinociceptive properties of morphine","volume":"279","author":"Cicero TJ","year":"1996","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0022-3565(24)36831-4","article-title":"Sex\u2010related differences in morphine's antinociceptive activity: Relationship to serum and brain concentrations","volume":"282","author":"Cicero TJ","year":"1997","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00353-9"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)01364-X"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000453"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(00)00015-4"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(01)00376-1"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602539608994011"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0022-3565(24)29556-2","article-title":"Sex\u2010related differences in antinociception and tolerance development following chronic intravenous infusion of morphine in the rat: Modulatory role of testosterone via morphine clearance","volume":"297","author":"South SM","year":"2001","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_6_14_2","volume-title":"Experimental Endocrinology: A Source Book of Basic Techniques","author":"Zarrow MX","year":"1964"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(91)90168-W"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199804000-00013"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/S0022-3565(24)37729-8","article-title":"Apparent insensitivity of the hotplate latency test for detection of antinociception following intraperitoneal, intravenous or intracerebroventricular M6G administration to rats","volume":"286","author":"South SM","year":"1998","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"e_1_2_6_18_2","volume-title":"Biopharmaceutics and Clinical Pharmacokinetics","author":"Gibaldi M.","year":"1984"},{"key":"e_1_2_6_19_2","volume-title":"Clinical Pharmacokinetics: Concepts and Applications","author":"Rowland M","year":"1995"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90633-7"},{"key":"e_1_2_6_21_2","unstructured":"Harlan.Research models: Sprague\u2010Dawley rat growth curves.2007. Available from:http:\/\/www.harlan.com\/us\/index.htm(accessed 26 October 2007)."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(00)00209-X"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(02)00925-5"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200112000-00003"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00201-7"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920007779315026"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90619-3"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90441-J"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(93)90056-U"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90065-J"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(95)00198-0"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000059225.40049.99"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(99)00020-X"},{"key":"e_1_2_6_34_2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0022-3565(24)36827-2","article-title":"Sex differences in opioid antinociception","volume":"282","author":"Bartok RE","year":"1997","journal-title":"J. Pharmacol. Exp. Ther"}],"container-title":["Clinical and Experimental Pharmacology and Physiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1681.2008.05019.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1681.2008.05019.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T07:07:09Z","timestamp":1738307229000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1681.2008.05019.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1440-1681.2008.05019.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1681.2008.05019.x","archive":["Portico"],"relation":{},"ISSN":["0305-1870","1440-1681"],"issn-type":[{"value":"0305-1870","type":"print"},{"value":"1440-1681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}